Home/Filings/4/0001790340-25-000119
4//SEC Filing

Feinberg Peter 4

Accession 0001790340-25-000119

CIK 0001790340other

Filed

Sep 30, 8:00 PM ET

Accepted

Oct 1, 8:59 AM ET

Size

7.2 KB

Accession

0001790340-25-000119

Insider Transaction Report

Form 4
Period: 2025-09-30
Transactions
  • Purchase

    Class A Common Stock

    2025-09-30$7.03/sh+7,500$52,730149,266 total
Holdings
  • Class A Common Stock

    (indirect: By LLC)
    476,615
  • Class A Common Stock

    (indirect: General Partner of PF Associates L.P.)
    392,242
  • Class A Common Stock

    (indirect: By LLC)
    115,441
Footnotes (1)
  • [F1]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $7.0049 to $7.055. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.

Issuer

Immuneering Corp

CIK 0001790340

Entity typeother

Related Parties

1
  • filerCIK 0001870076

Filing Metadata

Form type
4
Filed
Sep 30, 8:00 PM ET
Accepted
Oct 1, 8:59 AM ET
Size
7.2 KB